Neuchatel, Switzerland --(GANACSIGA) - Masimo (NASDAQ: MASI) ayaa maanta ku dhawaaqday natiijada daraasad dib-u-eegis ah oo lagu daabacay joornaalka Caalamiga ah ee Cilmi-baarista Carruurta. Masimo EMMA® capnometer la qaadan karo "waxaa loo istcimaali karaa in lagu qiimeeyo heerka neefsiga ee carruurta lagu sameynayo tracheotomy." ma jiro is-habayn joogto ah, waxa uu leeyahay wakhtiga diirimaad ee ugu yar, waxana uu soo bandhigaa saxa ah ee dhamaadka-tidal carbon dioxide (EtCO2) iyo cabbirada heerka neefsiga iyo sidoo kale qaab EtCO2 oo joogto ah 15 sekan gudahood.
Iyadoo la ogaanayo qiimaha suurtagalka ah ee hab isku dhafan oo la qaadi karo si loola socdo isbeddelada xaaladda neefsiga ee bukaanada xaaladaha aan caadiga ahayn qalabka la socodka isbitaalka bukaan-jiifka, Dr. Masashi Hotta iyo asxaabtiisuba waxay doonayeen inay qiimeeyaan waxtarka EMMA capnography ee carruurta iyagoo is barbar dhigaya. xogta laga helay EtCO2 qiyamka qalabka EMMA (ku lifaaqan dhamaadka fog ee tube tracheostomy) iyo invasively qiyaasay cadaadiska qayb venous ee carbon dioxide (PvCO2) for tracheotomy. Halka cadaadiska qayb arterial ee carbon dioxide (PaCO2) loo arkaa dahab ah halbeegga lagu qiimeeyo heerka neefsiga, cilmi-baarayaashu waxay doorteen PvCO2 sababtoo ah "qaadista shaybaarka halbowlaha ayaa aad uga xun qaadashada shaybaarada xididdada", iyagoo xusay in daraasaduhu ay muujiyeen in PaCO2 iyo PvCO2.2,3 ay qorteen 9 dhallaanka ah (da'da dhexdhexaadka ah 8 bilood) iyo marka la barbardhigo a wadarta 43 lammaane ee akhrinta EtCO2-PvCO2.
Cilmi-baadhayaashu waxay heleen isku-xirnaanta udhaxeysa akhrinta EtCO2 iyo PvCO2 ee 0.87 (95% kalsoonida kalsoonida 0.7 - 0.93; p <0.001) . % xadka heshiiska wuxuu ahaa 1.0 - 19.1 mmHg) .Cilmi-baadhayaashu waxay qiyaasayaan in isbeddelka EtCO2 uu ka hooseeyo PvCO2 lagu sharxi karo "gaaska isku dhafka ah ee u dhow tuubada tracheostomy sababtoo ah joogitaanka meel dhintay anatomical iyo physiological. Tubooyinka aan katiinado lahayn, tani waxa laga yaabaa inay dhacday Qaar ka mid ah qulqulka, sidoo kale, saddex-meelood laba meel bukaannada ayaa qaba [cudurka sambabada ee joogtada ah ama bronchopulmonary dysplasia], taas oo ay tilmaameen inay gacan ka geysato CO2 inta lagu jiro neefsashada marka la barbardhigo cadaadiska qayb ahaan CO2 dhiiga ku jira Xidhiidhka ayaa yaraatay.
Waxa kale oo ay ogaadeen in kala duwanaanshaha dhexdhexaadka ah ee akhrinta la soo ururiyey marka bukaanadu helayaan hawo farsamo oo aad u weyn (28 ee 43 xogta lammaane) . Farqiga dhexdhexaadka ah wuxuu ahaa 11.2 mmHg (6.8 - 14.3) isticmaalka hawo-mareenka iyo 6.6 mmHg (4.1 - 9.0) oo aan lahayn hawo-mareen (p = 0.043) .Cilmi-baadhayaashu waxay xuseen in isticmaalka hawo-mareenku uu si weyn ula xiriiro kala duwanaanshaha akhrinta lammaanaha sababtoo ah bukaannada hawo-mareenada ayaa lahaa xaalado neefsasho ama wareegga wareegga.
"Waxaan muujineynaa xiriir wanaagsan oo ka dhexeeya PvCO2 iyo EtCO2 waxaanan muujineynaa isticmaalka iyo faa'iidada capnometer-ka ee carruurta ku jirta tracheotomy," cilmi-baarayaashu waxay soo gabagabeeyeen, "EMMA waxaa loo isticmaali karaa in lagu qiimeeyo xaaladda neefsiga ee carruurta ku jirta tracheotomy. EMMA waxay si gaar ah faa'iido u leedahay goobaha daryeelka guriga iyo goobaha bukaan socodka ee carruurtan oo kale."Waxay sidoo kale xuseen, "Awoodda ugu weyn ee daraasaddan ayaa ah inaan isticmaalnay capnometer la qaadi karo si loo qiimeeyo EtCO2."
Masimo (NASDAQ: MASI) waa shirkad tignoolajiyada caafimaadka caalamiga ah oo horumarisa oo soo saarta tignoolajiyada hormoodka u ah warshadaha, oo ay ku jiraan cabbirada hal-abuurka leh, dareemayaasha, kormeerayaasha bukaanka, iyo qalabaynta iyo xalalka isku xidhka. Waxa la soo bandhigay 1995, Masimo SET® Measure-through Motion and Low Perfusion ™ pulse oximeter ayaa caddeeyey waxqabadkeeda marka loo eego tignoolajiyada kale ee garaaca wadnaha ee in ka badan 100 daraasado madax-banaan iyo ujeedo leh. oo loo muujiyey inay ka caawiso daaweeyayaasha inay yareeyaan xanuunka indhaha ee ba'an ee dhallaanka aan dhalan, 5 waxay wanaajisaa baadhista CCHD ee dhallaanka cusub, waxayna yaraynaysaa dadaalka kooxda jawaabta degdega ah marka la isticmaalayo Masimo Patient SafetyNet™ ee kormeerka joogtada ah ee qaybta qalliinka kadib.Dhaqdhaqaaqa, wareejinta ICU iyo kharashka Roll,11 oo ah mid ka mid ah isbitaallada 10 ee ugu sarreeya ee 9 garaaca wadnaha wadnaha ugu weyn.12 Masimo wuxuu sii wadaa inuu hagaajiyo SET®, 2018 wuxuu ku dhawaaqay in RD SET® dareemayaasha SpO2 saxnaanta ee xaaladaha dhaqdhaqaaqa ayaa si weyn u fiicnaaday, siinta daaweeyayaasha kalsooni weyn 2005, Masimo waxay soo bandhigtay tignoolajiyada rainbow Pulse CO-Oximetry, kaas oo awood u siinaya kormeer aan fiicneyn oo joogto ah oo ku saabsan qaybaha dhiigga ee horey loo cabiray oo kaliya, oo ay ku jiraan wadarta hemoglobin (SpHb®) Waxa ku jira oksijiinta (SpOC™), karboxyhemoglobin (SpCO®), Methemoglobin (SpMet®), Pleth Variability Index (PVi®), RPVi™ ( qaansoroobaad® PVi) iyo Tusaha Kaydka Ogsajiinta (ORi™) 2013, Masimo ayaa bilaabay. Platform-ka Korjoogteynta Bukaan-socodka iyo Isku-xirka Bukaan-socodka ee Root®, oo laga dhisay xagga hoose si uu u noqdo mid dabacsan oo la fidin karo intii suurtagal ah si loo fududeeyo ku-darka tignoolajiyada kale ee Masimo iyo kormeerka dhinac saddexaad;Waxyaabaha muhiimka ah ee lagu daro Masimo waxaa ka mid ah la socodka shaqada maskaxda ee jiilka soo socda ee SedLine®, O3® ogsajiinta gobolka iyo ISA ™ capnography oo leh khadka muunad ee NomoLine U isticmaal noocyo kala duwan oo xaalado caafimaad iyo kuwo aan ahayn bukaan-socod, oo ay ku jiraan tignoolajiyada xidhan ee xadhig la'aanta ah sida Radius-7® iyo Radius PPG™, aaladaha la qaadi karo sida Rad-67™, Fingertip pulse oximeters sida MightySat® Rx iyo aaladaha noqon kara loo isticmaalo cisbitaalka iyo guriga sida Rad-97®. Automation Hospital Masimo iyo xalalka isku xidhka waxa xuddun u ah Masimo Hospital Automation™ platform waxana ka mid ah Iris® Gateway, iSirona™, Patient SafetyNet, Replica™, Halo ION™, UniView ™, UniView:60™ iyo Masimo SafetyNet™. Wixii macluumaad dheeraad ah oo ku saabsan Masimo iyo alaabteeda, booqo www.masimo.com. Daraasadaha kiliinikada ee la daabacay ee alaabta Masimo waxaa laga heli karaa www.masimo.com/evidence/featured-studies/feature /.
ORI iyo RPVi ma helin ogolaanshaha FDA 510 (k) mana lagu suuq geyn karo gudaha Mareykanka. Sumadda Bukaan-socodka SafetyNet waxaa lagu isticmaalaa shatiga Jaamacadda HealthSystem Consortium.
War-saxaafadeedkan waxa ku jira odhaahyo horudhac u ah macnaha Qaybta 27A ee Xeerka Securities ee 1933 iyo Qaybta 21E ee Xeerka Sarifka Lacagaha ee 1934 marka loo eego Xeerka Dib-u-habaynta Dacwadaha Damaanad Gaarka ah ee 1995 Odhaahyada ku saabsan waxtarka EMMA®. sababa in natiijooyinkeena dhabta ahi ay ka duwanaadaan kuwa khataraha kala duwan ay ugu wacan yihiin Qodobada ka qayb qaadanaya khataraha aynu ku muujinayno bayaankeena mustaqbalka fog waxa ka mid ah, laakiin aan ku xaddidnayn: khataraha la xidhiidha malo-awaalkayaga ku saabsan soo saarista natiijooyinka caafimaad;ee la xidhiidha aaminsanaanta in tignoolajiyada cabbiraadda gaarka ah ee Masimo, oo ay ku jirto EMMA, ay gacan ka geysato khataraha caafimaad ee togan ee la xidhiidha natiijooyinka iyo badbaadada bukaanka;khataraha la xidhiidha aaminsanaantayada in horumarka caafimaad ee Masimo ee aan duulaanka ahayn ay bixiyaan xalal kharash-ku-ool ah iyo faa'iidooyin gaar ah;khataraha la xidhiidha COVID-19;iyo fayl-garayntayada Komishanka Securities and Exchange ("SEC") Qodobo dheeraad ah oo lagaga hadlay qaybta "Arimaha Khatarta" ee warbixintii u dambaysay waxa laga heli karaa lacag la'aan mareegaha SEC ee www.sec.gov.In kasta oo aanu aaminsanahay in waxa laga filayo Marka la eego odhaahdayada mustaqbalka-muuqaalka ahi waa macquul, ma garanayno in rajadayadu ay sax noqon doonto iyo in kale Ku-tiirsanaan aan munaasib ahayn oo ku saabsan odhaahyadan mustaqbalka-soo-jiidka ah, ee hadlaya maanta oo keliya. Annagu waajib nagama saarno inaan cusboonaysiino, dib-u-eegno ama caddaynno bayaannadan ama "Arimaha Khatarta" ee ku jira warbixintii ugu dambeysay ee SEC, haddii ay tahay natiijada macluumaadka cusub , dhacdooyinka mustaqbalka ama haddii kale, marka laga reebo sida looga baahan karo sharciyada dammaanadda ee khuseeya.
Daraasad cusub ayaa ogaatay in Masimo EMMA® Capnograph loo isticmaali karo si loo qiimeeyo neefsashada carruurta leh tracheostomy.
Waqtiga boostada: Juun-20-2022